ILLEGAL Biolab DISCOVERED in QUIET Neighborhood

Two white laboratory rats interacting in a cage

Federal agents just uncovered a suspected illegal biolab in a Las Vegas residential neighborhood—owned by the same Chinese nationals behind a 2023 California biolab scandal involving fraudulent COVID test kits and genetically engineered mice, raising serious questions about how foreign operatives continue exploiting gaps in U.S. regulatory oversight to endanger American communities.

Story Snapshot

FBI raided a northeast Las Vegas home on February 1, 2026, discovering biological materials and vials linked to Jia Bei Zhu, a Chinese national arrested in 2023 for operating an illegal California biolab
The property owners used shell companies and aliases to conceal operations spanning Nevada and California, distributing hundreds of thousands of misbranded medical test kits
Authorities found refrigerators with unknown liquids at the Las Vegas site, mirroring the 2022 Reedley, California discovery where officials uncovered transgenic mice and unlabeled biohazards
No illnesses or Airbnb rental activity confirmed at the Las Vegas location, despite initial reports suggesting otherwise

FBI Raid Exposes Cross-State Biolab Network

FBI agents and Las Vegas Metropolitan Police descended on a Sugar Springs home in northeast Las Vegas on Saturday, February 1, 2026, after a code violation escalated to the Joint Terrorism Task Force. Hazardous materials teams discovered refrigerators containing vials of unidentified liquids, prompting an extensive investigation. Property records reveal the home belongs to an LLC controlled by Jia Bei Zhu and Zhaoyan Wang, the same duo behind a notorious 2023 California biolab case. Clark County Sheriff Kevin McMahill assured residents the incident posed no public threat, but the discovery underscores alarming vulnerabilities in how foreign-linked entities operate undetected within American borders.

California Biolab Scandal Sets Precedent

The Las Vegas raid directly connects to a December 2022 investigation in Reedley, California, where code enforcement officials stumbled upon Prestige Biotech’s warehouse during a routine plumbing complaint. Inside, authorities discovered approximately 1,000 genetically engineered mice housed in inhumane conditions, alongside packaging operations for misbranded COVID-19, HIV, pregnancy, and urinalysis test kits. Zhu, operating under aliases including David He and Jesse Zhu, lied to FDA officials about his identity while his companies—Universal Meditech Inc. and Prestige Biotech Inc.—distributed hundreds of thousands of unapproved diagnostic devices between December 2020 and March 2023. The Department of Justice arrested the 62-year-old Chinese citizen in October 2023 for fraud and false statements.

Regulatory Failures Enable Foreign Operations

This case exposes how inadequate federal oversight allowed Zhu and Wang to exploit pandemic-era demand for cheap medical tests while evading basic safety protocols. The couple used romantic and business ties to establish shell companies across multiple states, disguising industrial operations within warehouses and residential properties. Fresno County health officials documented blood, tissue samples, and bodily fluids at the California site—materials that could pose biohazard risks if mishandled. Yet these operations persisted for years before accidental discovery through municipal code enforcement, not proactive federal monitoring. This represents a fundamental failure to protect Americans from unregulated foreign biotech actors who view our regulatory gaps as opportunities for profit.

National Security Implications Demand Action

The presence of transgenic mice engineered to model human COVID-19 infection raises questions beyond simple fraud—these materials could theoretically support bioweapons research if diverted. While Sheriff McMahill emphasizes the investigation remains isolated, the pattern of concealment through aliases and cross-state properties suggests deliberate attempts to avoid scrutiny. A property manager was arrested Saturday, though Zhu himself was not detained as of Sunday. The Trump administration must prioritize closing loopholes that allow foreign nationals to establish clandestine biological operations on American soil. This isn’t about trade or legitimate scientific collaboration—it’s about safeguarding communities from actors who deliberately deceive regulators while handling potentially dangerous biological materials in residential neighborhoods where families live.

Federal agencies now face pressure to explain how Zhu continued operating after his 2023 arrest, expanding into Nevada while facing charges. The ongoing investigation must deliver accountability and systemic reforms to prevent similar operations from threatening public health and national security. Americans deserve transparency about what materials were found, what risks they posed, and how many other properties these operators control across the country.